Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02CGC
|
||||
Former ID |
DCL000270
|
||||
Drug Name |
Sorbinil
|
||||
Synonyms |
SBI; Sorbinilo; Sorbinilum; Sorbinilo [Spanish]; Sorbinilum [Latin]; CP 45634; CP-45634; Sorbinil (USAN/INN); D-6-fluoro-spiro(chroman-4,4'-imidazolidine)-2',5'-dione; (4S)-6-fluoro-2,3-dihydro-2'H,5'H-spiro[chromene-4,4'-imidazolidine]-2',5'-dione; (4S)-6-fluorospiro[2,3-dihydrochromene-4,5'-imidazolidine]-2',4'-dione
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Pfizer
|
||||
Structure |
Download2D MOL |
||||
Formula |
C11H9FN2O3
|
||||
InChI |
InChI=1S/C11H9FN2O3/c12-6-1-2-8-7(5-6)11(3-4-17-8)9(15)13-10(16)14-11/h1-2,5H,3-4H2,(H2,13,14,15,16)/t11-/m0/s1
|
||||
InChIKey |
LXANPKRCLVQAOG-NSHDSACASA-N
|
||||
CAS Number |
CAS 68367-52-2
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
464383, 592669, 7890393, 7979348, 8898992, 12012698, 12016145, 15121785, 29215399, 37528353, 46504981, 46509502, 47207554, 48416546, 57401740, 74547229, 81066946, 87350465, 92098531, 103165545, 104540744, 104828809, 121360915, 128553726, 134338927, 134339157, 135009326, 137004922, 139060526, 141287583, 144205232, 160965885, 163726552, 170466611, 172919578, 175612299, 178103987, 179150924, 184547797, 198935949, 223454546, 226432735, 241120591
|
||||
Target and Pathway | |||||
Target(s) | Aldose reductase | Target Info | Inhibitor | [536032], [537789] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References | |||||
Ref 542439 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7415). | ||||
Ref 544510 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000008) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.